Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze AXSM stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate AXSM investment potential.

What is AXSM stock price today?

Get real-time AXSM stock price, historical data, and price charts on Financhill. Track AXSM performance with our advanced analysis tools.

Is AXSM a good investment?

Evaluate AXSM investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy AXSM stock?

To buy AXSM stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of AXSM?

View detailed market capitalization data and company valuation metrics for AXSM on our comprehensive analysis page.

What is the P/E ratio of AXSM?

Use our fundamental analysis tools to view AXSM P/E ratio and compare valuation metrics with industry peers.

What are AXSM earnings?

View AXSM earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Axsome Therapeutics, Inc. Stock Predictions

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Buy

AXSM
Axsome Therapeutics, Inc.

Last Price:

$147.00

Seasonality Move:

15.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

Axsome Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Axsome Therapeutics, Inc. has on average historically risen by 147.3% based on the past 10 years of stock performance.
Axsome Therapeutics, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Is Axsome Therapeutics, Inc. Stock Undervalued?

The current Axsome Therapeutics, Inc. [AXSM] share price is $146.87. The Score for AXSM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
AXSM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Axsome Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Axsome Therapeutics, Inc. has on average historically risen by 147.3% based on the past 10 years of stock performance.

Axsome Therapeutics, Inc. Stock Rating

Buy

Axsome Therapeutics, Inc. (AXSM) is a Buy

Is Axsome Therapeutics, Inc. overpriced?

Axsome Therapeutics, Inc. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Axsome Therapeutics, Inc. Stock Price History

Is AXSM stock going to rise?

The current trend is moderately bullish and AXSM is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Pharmaceuticals

Sector:

Health Care

Type:

stock

Website:

axsome.com

52-Week Data

52-Week High:

152.94

52-Week Low:

75.56

Prediction Charts

Market Cap:

7.4B

Price in USD:

146.87

Volume:

303.8K

Beta:

1.54

Technical Analysis

SMA50:

138.24

SMA100:

126.57

SMA200:

118.13

52-Wk Change:

63.77%

Stock Predictions

Is Axsome Therapeutics, Inc. stock public?

Yes, Axsome Therapeutics, Inc. is a publicly traded company.
What is the Axsome Therapeutics, Inc. stock quote today?

The Axsome Therapeutics, Inc. stock price is 146.87 USD today.
How to buy Axsome Therapeutics, Inc. stock online?

You can buy Axsome Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-26	150.01	150.98	152.00	147.97
Nov-28	151.77	151.50	152.76	150.06
Dec-1	150.00	149.03	151.58	148.55
Dec-2	149.24	142.09	149.25	141.69
Dec-3	142.89	147.81	148.72	142.62
Dec-4	147.63	148.04	149.93	147.50
Dec-5	148.00	149.22	151.63	147.60
Dec-8	150.77	147.56	151.51	147.47
Dec-9	146.99	145.22	148.54	144.00
Dec-10	145.12	149.26	149.87	144.97
Dec-11	149.75	148.75	150.00	146.34
Dec-12	148.67	148.17	148.85	144.13
Dec-15	148.36	146.24	149.13	145.10
Dec-16	146.76	146.87	148.21	145.07

Axsome Therapeutics, Inc. Earnings

Axsome Therapeutics, Inc. Earnings Report: Per Share Axsome Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Axsome Therapeutics, Inc. Forecast Revenue Growth

Axsome Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Axsome Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $1.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.39 per share, and an increase next year of $4.12 per share.

* Axsome Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.